Lipid, apolipoprotein AI and B levels in Ivorian patients with sickle cell anaemia

Annales de Biologie Clinique

Volumn 54, Issue 7, 1996, Pages 285-288

  Monnet, D ^a   Kane F ^a   Konan Waidhet, D ^b   Diafouka, F ^a   Sangare A ^c   Yapo, A E ^a  

^a INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^b Inst Natl de la S Publique   (Côte d’Ivoire)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE YOPOUGON   (Côte d’Ivoire)

Author keywords

Anaemia sickle cell; Apolipoprotein AI; Apolipoprotein B; Cholesterol; Ivorian patients; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HEMOGLOBIN A; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COTE D'IVOIRE; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SICKLE CELL ANEMIA; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; APOLIPOPROTEINS A; APOLIPOPROTEINS B; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COTE D'IVOIRE; FEMALE; HUMANS; LIPIDS; MALE; TRIGLYCERIDES;

EID: 0029805406     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Cabannes R, Sendrail A, Pène F, Sangaré A, Sombo MF, Kplé FP (1979) Élude de l'hémotypologie des populations de l'Afrique de l'Ouest. Référence particulière aux populations ivoiriennes et aux Peuls. Ann Univ Abidjan Ser Med 13, 105-135
2. Hebbel RP (1991) Beyond hemoglobin polymerisation: the red blood cell membrane and sickle cell disease physiopathology. Blood 77, 214-237
3. Benjamin LJ (1986) Biochemical and cellular alteration in sickle cell anemia: crisis markers and therapeutic monitors. In: Approaches to therapeutic of sickle cell anemia. (Beuzard Y, Charache S, Galacteros F, eds). Inserm, Paris, 451-454
4. Monnet D, Diallo I, Sangaré A, Yapo AE (1993) Intérét clinique du dosage de la protéine C-réactive, de l'α1-glycoprotéine acide et de la transferrine au cours de la drépanocytose homozygote. Bull Soc Pathol Exot 86, 282-285
5. Bursaux E, Poyart C (1983) Structural and functional alterations of the erythrocyte membrane in sickle cell anaemia. Bull Eur Physiopathol Respir 19, 345-350
6. Platts OS (1989) Pathology of membrane proteins in sickle erythrocytes. Ann NY Acad Sci 565, 83-85
7. Rice-Evans C, Omorphos SC, Baysal E (1986) Sickle cell membranes and oxidative damage. Biochem J 237, 265-269
8. Jain SK, Ross JD, Levy GJ, Little RL, Duett J (1989) The accumulation of malonyldialdehyde, an end product of membrane lipid peroxidation, can cause potassium leak in normal and sickle red blood cells. Biochem Med Metab Biol 42, 60-65
9. Sess D, Carbonneau MA, Thomas MJ, Dumon MF, Peuchant E, Perromat A, Le Bras M, Clerc M (1992) Premières observations sur les principaux paramètres plasmatiques du stress oxydatif chez le drépanocytaire homozygote. Bull Sac Pathol Exot 85, 174-179
10. Erasmus RT, Olukoga AO, Ojuawo O (1990) Plasma lipids and lipoproteins in nigerian children with sickle cell anaemia. Ann Tropical Paediatr 10, 421-423
11. El-Hazmi MAF, Jabbar FA, Warsy AS (1987) Cholesterol and triglyceride level in patients with sickle cell anaemia. Scand J Clin Lab Invest 41, 351-354
12. Monnet D, Kacou E, Gershy-Damet A, Lonsdorfer A, Odéhouri K, Yapo AE (1991) Acute phase proteins and nutritional markers in HIV infection. Ann Biol Clin 49, 428-432
13. Cano MD, Gonzalvo C, Scheen A J, Castillo MJ (1994) Measurement of apolipoproteins B and A by radial immunodiffusion: methodological assessment and clinical applications. Ann Biol Clin 52, 657-661
14. Yapo AE, Assayi M, Aka NB, Bonetto R, Comoé L, Lonsdorfer A, Monnet D, Diaine C (1990) Les valeurs de références de 21 constituants biochimiques sanguins de l'ivoirien adulte présumé sain. Pub Méd Afr 110, 49-57
15. Djoumessi S, Zekeng G, Lando G, Zeukeng D (1994) Serum lipids and atherogenic risk in sickle-cell trait carriers. Ann Biol Clin 52, 663-665
16. Sasaki J, Waterman MR, Buchanan GR, Cottam GL (1983) Plasma and erythrocyte lipids in sickle cell anaemia. Clin Lab Haematol 5, 35-44
17. Saile R, Fruchart JC (1990) L'apolipoprotéine sérique amyloïde A (apo SAA). Implication dans l'inflammation et dans les modifications des lipoprotéines. Ann Biol Clin 48, 77-85
18. Benditt EP, Eriksen N (1977) Amyloid protein SAA is associated with high density lipoproteins from human serum. Proc Natl Acad Sci USA 74, 4025-4030
19. Parks JS, Rudel LL (1985) Alteration of high density lipoproteins sub-fraction distribution with induction of serum amyloid protein (SAA) in the nonhuman primate. J Lipid Res 45, 97-101
20. Hebbel RP, Eaton JW, Balasingam M, Steinber MH (1982) Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 70, 1253-1259
21. Fong LG, Parthasarathy S, Witztum JL, Steinberg D (1987) Non-enzymatic oxidative cleavage of peptide bonds in apolipoprotein B100. J Lipid Res 28, 1466-1468
22. Reyftmann JP, Santus R, Mazière JC, Morliere P, Salmon S, Candide C, Mazière C, Haigle J (1982) Sensitivity of tryplophan and related compounds to oxidation induced by lipid autoperoxidation. Application to human serum low- and high-density lipoproteins. Biochim Biophys Acta 710, 172-176.
23. Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg D (1987) Decrease in reactive amino-groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-medialed catabolism. Arteriosclerosis 7, 135-138
24. Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D (1986) Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 6, 505-507
25. Berreras L, Diggs L W, Lipscomb A (1966) Plasma volume in sickle cell disease. South Med J 59, 456-458
26. Jenkins ME, Scott RB, Ferguson AD (1956) Studies in sickle cell anaemia. Blood volume relationship and the use of plasma extender in sickle cell disease in childhood: a preliminary report. Pediatrics 18, 239-447
27. Fruchart JC, Bertand M, Parra H, Gentilini JL, Boniface M (1982) Lipoprotéines et apolipoprotéines plasmatiques : intérêt de leurs dosages dans le dépistage de l'athérosclérose coronarienne. Comparaison avec les informations fournies par coronarographie. Nouv Presse Méd, 11, 3491-3497
28. Pech MA, Myara J, Vedie B, Moatti N (1992) LDL modifiées et athérosclérose. Nature des modifications Propriétés physicochimiques et biologiques. Ann Biol Clin 50, 213-227
29. Wald NJ, Law M, Watt CH, Wu T, Bailey A, Johnson AM, Craig WY, Ledue TB, Haddow JE (1994). Apolipoproteins and ischaemic heart disease : implications for screening. Lancet 343, 75-79